Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Type 2 Diabetes Mellitus (T2DM) is a rapidly growing global health problem with increasing prevalence. from 2016‐2019 and secondary diagnosis of T2DM. from 2016‐2019 and secondary diagnosis of T2DM. Of those patients, 35.43% (n=273,993) were diabetic and 64.57% (n=151,112) were non‐diabetic.

Diabetes 40

Diabetes Coronary Artery Disease Atrial Fibrillation Dementia 40

Dr. Paddy Barrett

AUGUST 15, 2023

Insulin resistance is a core risk factor for the three leading causes of death: Cardiovascular Disease Cancer Dementia. Just for clarity, type 2 diabetes is when insulin resistance progresses to the point that your body can no longer keep your blood glucose levels under control. Subscribe now Take cardiovascular disease, for example.

Blood Pressure 52

Blood Pressure Risk Factors Diabetes Cholesterol 52

Stroke Journal

JANUARY 30, 2025

Background:Vascular risk factors, particularly in midlife, are associated with an increased risk of dementia, and smoking has been inversely associated with Parkinson's disease (PD) risk, but the role of these factors in PD-dementia (PDD) is less clear. yo, and 1,791 developed dementia/no PD at a mean age of 79.7

Dementia 40

Dementia Risk Factors Atherosclerosis Obesity 40

Stroke Journal

DECEMBER 5, 2024

Participants underwent brain magnetic resonance imaging scans every 3 to 4 years between 2005 and 2016. Cerebral blood flow (CBF) was measured through 2-dimensional phase-contrast magnetic resonance imaging; the cerebrovascular resistance index (CVRi) was defined as the ratio of mean arterial blood pressure to total CBF.

Blood Pressure 40

Blood Pressure Dementia Cardiovascular Disease Diabetes 40

Stroke Journal

JANUARY 30, 2025

While it is generally held that faster reperfusion is associated with better patient outcomes, the magnitude of benefit in achieving the goal of DTD </= 90 has not been systematically studied.Methods:This is a retrospective analysis of acute ischemic stroke (AIS) patients from a multi-state stroke registry between January 2016 through March (..)

Outcomes 40

Outcomes Atrial Fibrillation Dementia Stroke 40

Dr. Malcolm Kendrick

OCTOBER 30, 2024

(2022-25) Swiss Reinsurance Company: £645K China Kadoorie Biobank (2002-ongoing) AstraZeneca: $300K Bayer AG: £300K GlaxoSmithKline: £3.6M Elinogrel feasibility trial (2010-2011) Novartis: £500K EMPA-KIDNEY (2017-ongoing) Boehringer Ingelheim: £106.3M Establishing Fuwai-Oxford research centre (2010-ongoing) Merck: £1.1M

Cholesterol 145

Cholesterol Article Research Diet 145